Drug Trial Radar · NCT00909181
Study of Topically Administered Oxybutynin Gel in Patients With Urge Incontinence
Last checked: Nov 20, 2026Latest source record: Jul 2, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
626
Actual
Start
Mar 2009
Primary completion
Jul 2010
Study completion Nov 2010
Sponsor
- Lead sponsor
- Antares Pharma Inc.Industry
- Sponsor type
- Industry
- First posted
- May 27, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the double-blind phase of the study is to compare the effects of two doses of oxybutynin gel to placebo gel. The objective of the open-label extension is to evaluate the extended safety and skin-irritation profile of topically administered oxybutynin gel. The hypothesis is that topically administered oxybutynin gel will decrease (compared to placebo) the number of incontinence episodes per week, average daily urinary frequency, and urinary urgency; increase average urinary void volume; and improve patient quality of life.
Conditions
- Urge Urinary Incontinence
- Urinary Frequency
Interventions
OxybutyninDrug
Oxybutynin Gel. Transdermal gel was applied once-daily (in the morning) during 12 weeks of treatment. Evaluation: reduction of incontinent episodes (baseline vs 12 weeks); comparison 56 resp. 84 mg vs placebo
PlaceboDrug
Placebo Gel Oxybutynin Gel. Transdermal gel was applied once-daily (in the morning) during 12 weeks of treatment. Evaluation: reduction of incontinent episodes (baseline vs 12 weeks); comparison 56 resp. 84 mg vs placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Mean Weekly Frequency of Urinary Incontinence Episodes at Week 12Time frame: 12 weeks
Locations
55 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Birmingham, Alabama
Site not named
Little Rock, Arkansas
Site not named
Laguna Hills, California
Site not named
Los Angeles, California
Site not named
San Diego, California
Site not named
San Diego, California
Site not named
Farmington, Connecticut
Site not named
New Britain, Connecticut
Site not named
New Port Richey, Florida
Site not named
North Miami, Florida
Site not named
Pembroke Pines, Florida
Site not named
Sarasota, Florida
Site not named
St. Petersburg, Florida
Site not named
Tampa, Florida
Site not named
Wellington, Florida
Site not named
Columbus, Georgia
Site not named
Sandy Springs, Georgia
Site not named
Stockbridge, Georgia
Site not named
Evanston, Illinois
Site not named
West Des Moines, Iowa
Site not named
Shreveport, Louisiana
Site not named
Annapolis, Maryland
Site not named
Towson, Maryland
Site not named
Watertown, Massachusetts
Site not named
Grand Rapids, Michigan
Site not named
Saginaw, Michigan
Site not named
Chesterfield, Missouri
Site not named
Las Vegas, Nevada
Site not named
Brooklyn, New York
Site not named
Endwell, New York
Site not named
Kingston, New York
Site not named
Poughkeepsie, New York
Site not named
Williamsville, New York
Site not named
Cary, North Carolina
Site not named
Charlotte, North Carolina
Site not named
Harrisburg, North Carolina
Site not named
Raleigh, North Carolina
Site not named
Raleigh, North Carolina
Site not named
Salisbury, North Carolina
Site not named
Wilmington, North Carolina
Showing 40 of 55 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.